1519 Avelumab combined with regorafenib in solid tumors with tertiary lymphoid structures: a phase 2 REGOMUNE trial cohort

• Antoine Adenis,
• Antoine Italiano,
• Carine Bellera,
• Philippe Cassier,
• Alban Bessede,
• Rastilav Bahleda,
• Jean-Philippe Metges,
• Sophie Cousin,
• Jean-Philippe Guégan,
• Coralie Cantarel,
• Michèle Kind,
• Jean Palussiere,
• Lucile Vanhersecke

Affiliations

Antoine Adenis

6Institut du Cancer de Montpellier, Montpellier, France

Antoine Italiano

4Institut Bergonié, Bordeaux, France

Carine Bellera

1Institut Bergonié, Bordeaux, France

Philippe Cassier

8Centre Leon Berard, Lyon, France

Alban Bessede

5Explicyte, Bordeaux, France

Rastilav Bahleda

5Gustave Roussy, Villejuif, Ile de France, France

Jean-Philippe Metges

5Hopital Augustin Morvan, Brest, France

Sophie Cousin

3Institut Bergonié, Bordeaux, France

Jean-Philippe Guégan

2Explicyte Immuno-Oncology, Bordeaux, Gironde, France

Coralie Cantarel

1Institut Bergonié, Bordeaux, France

Michèle Kind

1Institut Bergonié, Bordeaux, France

Jean Palussiere

1Institut Bergonié, Bordeaux, France

Lucile Vanhersecke

3Institut Bergonie, Bordeaux, Gironde, France